These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 3122485)

  • 41. [Anti-phospholipid antibodies and pathological conditions].
    Koike T
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):506-15. PubMed ID: 1902588
    [No Abstract]   [Full Text] [Related]  

  • 42. Characteristics of high-titer IgG antiphospholipid antibody in systemic lupus erythematosus patients with and without fetal death.
    Qamar T; Levy RA; Sammaritano L; Gharavi AE; Lockshin MD
    Arthritis Rheum; 1990 Apr; 33(4):501-4. PubMed ID: 2109614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticardiolipin antibodies in patients with systemic lupus erythematosus.
    Sturfelt G; Nived O; Norberg R; Thorstensson R; Krook K
    Arthritis Rheum; 1987 Apr; 30(4):382-8. PubMed ID: 3107577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracardiac thrombus in systemic lupus erythematosus associated with lupus anticoagulant.
    Lubbe WF; Asherson RA
    Arthritis Rheum; 1988 Nov; 31(11):1453-4. PubMed ID: 3142489
    [No Abstract]   [Full Text] [Related]  

  • 46. [Streptokinase therapy in a patient with lupus anticoagulant and thrombosis of the A. iliaca externa].
    Funk N; Stoyanova-Scholz M; Martin M; Bergerhausen HJ; Genth E; Fiebach BJ; Magnus L
    Vasa; 1989; 18(4):318-21. PubMed ID: 2514521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating lupus anticoagulant in a surgical temporomandibular joint patient. Report of a case.
    Carlson ER; Catone GA
    Oral Surg Oral Med Oral Pathol; 1988 Apr; 65(4):404-5. PubMed ID: 3129685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A case of systemic lupus erythematosus with lupus anticoagulant, complicating cerebral infarction and habitual abortions].
    Izumi R; Mayumi T; Nagasawa K; Shibuya T; Kusaba T; Yamauchi Y; Niho Y; Nagano M
    Nihon Naika Gakkai Zasshi; 1987 May; 76(5):740-1. PubMed ID: 3150975
    [No Abstract]   [Full Text] [Related]  

  • 49. The demonstration of lupus anticoagulant by an enzyme-linked immunoadsorbent assay.
    Branch DW; Rote NS; Scott JR
    Clin Immunol Immunopathol; 1986 May; 39(2):298-307. PubMed ID: 3084145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis.
    Canoso RT; de Oliveira RM
    Am J Hematol; 1988 Apr; 27(4):272-5. PubMed ID: 3128108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lupus anticoagulant associated syndrome in benign and malignant systemic disease.
    Dührsen U; Paar D; Brittinger G
    Klin Wochenschr; 1987 Sep; 65(17):818-22. PubMed ID: 3116324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lupus anticoagulants in systemic lupus erythematosus: prevalence and clinical associations.
    Padmakumar K; Singh RR; Rai R; Malaviya AN; Saraya AK
    Ann Rheum Dis; 1990 Dec; 49(12):986-9. PubMed ID: 2125409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.
    Derksen RH; Hasselaar P; Blokzijl L; Gmelig Meyling FH; De Groot PG
    Ann Rheum Dis; 1988 May; 47(5):364-71. PubMed ID: 3133992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intracardiac thrombosis, phospholipid antibodies, and two-chambered right ventricle.
    Coppock MA; Safford RE; Danielson GK
    Br Heart J; 1988 Nov; 60(5):455-8. PubMed ID: 3144298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Separation of lupus anticoagulant from anticardiolipin antibodies by ion-exchange and gel filtration chromatography.
    Chamley LW; Pattison NS; McKay EJ
    Haemostasis; 1991; 21(1):25-9. PubMed ID: 1907590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Skin lesions associated with circulating lupus anticoagulant.
    Alegre VA; Gastineau DA; Winkelmann RK
    Br J Dermatol; 1989 Mar; 120(3):419-29. PubMed ID: 2496741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Blood coagulation changes in systemic lupus erythematosus].
    Liu WL; Xiu HZ; Sun HY
    Zhonghua Nei Ke Za Zhi; 1990 Dec; 29(12):717-9, 764. PubMed ID: 2128740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of the lupus anticoagulant.
    Espinoza LR; Hartmann RC
    Am J Hematol; 1986 Jul; 22(3):331-7. PubMed ID: 3087160
    [No Abstract]   [Full Text] [Related]  

  • 59. Simplified screening procedure for detecting lupus inhibitor.
    Gibson J; Starling E; Date L; Rickard KA; Kronenberg H
    J Clin Pathol; 1988 Feb; 41(2):226-8. PubMed ID: 3127429
    [No Abstract]   [Full Text] [Related]  

  • 60. Anticardiolipin versus lupus anticoagulant tests: no final judgment.
    Harris EN
    Ann Rheum Dis; 1989 Jan; 48(1):84-5. PubMed ID: 2493774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.